Versuchen GOLD - Frei

In India, there is still a big role for MSP

Mint Ahmedabad

|

September 06, 2025

Bedabrata Pain on his new documentary, the lessons from farmer distress in the US, and the need to extend minimum support price

- Prachi Pinglay-Plumber

When the farmer protests over the Union government's three farm laws stretched out in India in 2020-21, award-winning senior research scientist and filmmaker Bedabrata Pain began reading about it. The first thing he came across was farm suicides in the US. Pain, who won a National Award for his 2012 debut film Chittagong, realised there's a story to be told.

In 2021, Pain, who has previously worked at NASA, set off on a trip to explore farmer distress across the US and found that the privatisation and corporatisation of farming in the 1980s had not benefited farmers. The result of that trip is Déjà Vu, a documentary on the unexpected similarities between the plight of farmers in the US and in India. It delivers an ominous warning about how the free market squeezes small farmers out of the system and sometimes drives them to suicide.

Déjà Vu premiered at the International Documentary and Short Film Festival of Kerala in August. Pain describes it as "a challenging story to tell" because there were so many versions and angles to approach it from.

Ali Fazal and Naseeruddin Shah have voiced the film, which is co-produced by Resul Pookutty.

Pain, 62, who divides his time between India and the US, spoke to Lounge about the making of the documentary, the need to safeguard minimum support price (MSP), and the dangers of turning agriculture over to conglomerates. Edited excerpts from the interview.

Why did you think of making this documentary?

There is a question about Indians in the US—what their role is, what is their connection with India. And then there is pressure not to critique India or the US, the country you are from or the country you live in—and I have managed to do both.

WEITERE GESCHICHTEN VON Mint Ahmedabad

Mint Ahmedabad

Mint Ahmedabad

'If you're on trend, you are in trouble'

Patou creative head Guillaume Henry discusses the essence of couture and why simple is best

time to read

4 mins

December 13, 2025

Mint Ahmedabad

GST cuts, easing inflation drive rural demand revival

India’s rural economy expanded and recovered strongly in late 2025, with consumption, incomes and investment improving after a key tax reform and as inflation eased, a survey showed.

time to read

2 mins

December 13, 2025

Mint Ahmedabad

Mint Ahmedabad

Chair man, of the bored

STREAM OF STORIES

time to read

3 mins

December 13, 2025

Mint Ahmedabad

Mint Ahmedabad

Anju Dodiya creates disquieting worlds

Artist Anju Dodiya discusses the ideas, influences and inspiration behind her new solo show, 'The Geometry of Ash'

time to read

5 mins

December 13, 2025

Mint Ahmedabad

Bar hopping with Lounge

\"The things that make a cocktail really great are often very simple details—the frozen glass, the lemon twist—that transform two fingers of alcohol into an ice-glazed elixir,\" writes Alice Lascelles in her excellent guide to making cocktails at home, The Cocktail Edit.

time to read

1 mins

December 13, 2025

Mint Ahmedabad

New Delhi and France revise 1992 tax treaty

India and France have struck a deal to revise their 1992 treaty which will halve the tax on dividends paid by Indian units to French parents, potentially saving millions for companies with major operations in the South Asian nation, documents show.

time to read

1 min

December 13, 2025

Mint Ahmedabad

Ozempic debuts with a ₹2,200-a-week price tag

for chronic weight management, Novo Nordisk is positioning Ozempic as a treatment of type 2 diabetes with weight loss benefits, competing with Eli Lily’s Mounjaro that was launched in India in March.

time to read

1 mins

December 13, 2025

Mint Ahmedabad

Mint Ahmedabad

How 'puri-aloo' and 'chaat' unite Lucknow

Whenever my friends want to eat puri-aloo, they invite themselves over to my home.

time to read

5 mins

December 13, 2025

Mint Ahmedabad

Novo Nordisk debuts Ozempic at ₹2,200 a week

Danish drugmaker Novo Nordisk on Friday launched its blockbuster diabetes drug Ozempic in India, with a starting price of ₹2,200 per week.

time to read

1 mins

December 13, 2025

Mint Ahmedabad

Mint Ahmedabad

Govt’s insurance reform allows 100% FDI, composite licences

The government has paved the way for 100% foreign direct investment in the insurance sector, composite licences and easier capital requirements, among others sweeping reforms, as the Union cabinet cleared the enabling legislation, said two officials aware of the matter.

time to read

1 mins

December 13, 2025

Listen

Translate

Share

-
+

Change font size